Free Trial

Upstream Bio (UPB) News Today

Upstream Bio logo
$16.21 -0.40 (-2.41%)
(As of 12/20/2024 05:16 PM ET)
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Reaches New 52-Week Low - Should You Sell?
Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - What's Next?
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?
Upstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?
Upstream Bio Appoints Allison Ambrose as General Counsel
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Shares Down 5% - Time to Sell?
Upstream Bio (NASDAQ:UPB) Stock Price Down 5% - What's Next?
Upstream Bio to join Russell 2000 index
Upstream Bio Announces Addition to Russell 2000® Index
Upstream Bio, Inc. stock logo
Upstream Bio, Inc.'s (NASDAQ:UPB) Quiet Period Set To End on November 20th
Upstream Bio's (NASDAQ:UPB - Get Free Report) quiet period will expire on Wednesday, November 20th. Upstream Bio had issued 15,000,000 shares in its initial public offering on October 11th. The total size of the offering was $255,000,000 based on an initial share price of $17.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Upstream Bio Inc UPB
Upstream Bio, Inc. stock logo
Brokers Set Expectations for Upstream Bio Q4 Earnings
Upstream Bio, Inc. (NASDAQ:UPB - Free Report) - Analysts at William Blair issued their Q4 2025 earnings per share (EPS) estimates for Upstream Bio in a research report issued on Thursday, November 7th. William Blair analyst M. Phipps anticipates that the company will post earnings per share of ($
Upstream Bio, Inc. stock logo
William Blair Weighs in on Upstream Bio Q4 Earnings
Upstream Bio, Inc. (NASDAQ:UPB - Free Report) - Analysts at William Blair issued their Q4 2024 earnings per share (EPS) estimates for Upstream Bio in a report issued on Tuesday, November 5th. William Blair analyst M. Phipps expects that the company will post earnings of ($0.42) per share for the
Test tubes on blue background — Photo
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.
Upstream Bio, Inc. stock logo
Upstream Bio (NASDAQ:UPB) Earns Overweight Rating from Analysts at Piper Sandler
Piper Sandler initiated coverage on shares of Upstream Bio in a report on Tuesday. They issued an "overweight" rating and a $75.00 price target on the stock.
Get Upstream Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter.

The #1 Coin for November 2024 (Ad)

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

UPB Media Mentions By Week

UPB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

UPB
News Sentiment

0.40

0.60

Average
Medical
News Sentiment

UPB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

UPB Articles
This Week

7

2

UPB Articles
Average Week

Get Upstream Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:UPB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners